Blenrep 70 mg
Blenrep 70 mg is a medicine authorised by Swissmedic under authorisation number 69910. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 June 2025 and the authorisation is limited until 18 June 2030. ATC code L01FX15 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69910 |
|---|---|
| Name | Blenrep 70 mg |
| Full name | Blenrep 70 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FX15 |
| First authorisation | 19 June 2025 |
| Authorisation validity | 18 June 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Blenrep 70 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 19 June 2025 |
| 2 | Blenrep 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 19 June 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FX15 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FX15 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Blenrep 70 mg authorised in Switzerland?
Yes. Blenrep 70 mg is authorised by Swissmedic under authorisation number 69910, data as of 01 September 2026. The authorisation is limited until 18 June 2030.
Which dispensing category does Blenrep 70 mg have?
Blenrep 70 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Blenrep 70 mg?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.